Ocular Toxicity of Mirvetuximab
Conclusions:
Mirvetuximab soravtansine therapy can cause transient corneal toxicity. A short course of topical steroids can reduce the patient symptoms.
Source: Cornea - Category: Opthalmology Tags: Clinical Science Source Type: research
More News: Cancer | Cancer & Oncology | Epithelial Cancer | Eyes | Fallopian Tube Cancer | Opthalmology | Ovarian Cancer | Ovaries | Pain | Peritoneal Cancer | Science | Toxicology